Program Offering and Eligibility

If you have commercial insurance and meet the additional eligibility criteria below, you can get help with your ACTEMRA drug costs.

This program helps with the cost of ACTEMRA only. It does not help with the cost of other medicines you take at the same time as ACTEMRA or with facility fees.

 

Help with ACTEMRA drug costs

You may pay
$5 for each ACTEMRA treatment.*
You receive up to $15,000 every 12 months to help with your ACTEMRA drug costs.

 

*The final amount owed by patients may be as little as $5, but may vary depending on the patient's health insurance plan. Eligible commercially insured patients who are prescribed ACTEMRA for an FDA-approved use can receive up to $15,000 in assistance per 12-month period for drug costs. See terms and conditions. Program limits apply.

Note: This program helps pay for drug costs described as "out-of-pocket," "co-pay," "co-insurance" or "uncovered expense" for ACTEMRA only. It does not pay for the costs of other medicines or costs related to the office visit or infusion.

 

You may be eligible if you:
  • Are taking ACTEMRA for one of the following FDA-approved uses:
    • Moderately to severely active rheumatoid arthritis (RA) after at least one other medicine called a disease modifying antirheumatic drug (DMARD) has been used and did not work well (adult patients only)
    • Giant cell arteritis (GCA) (adult patients and subcutaneous use only)
    • Active polyarticular juvenile idiopathic arthritis (PJIA) (patients 2 years of age and older)
    • Active systemic juvenile idiopathic arthritis (SJIA) (patients 2 years of age and older)
    • Slowing the rate of decline in lung function in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD) (also known as scleroderma-associated ILD) (adult patients and subcutaneous use only)
  • Are 18 years of age or older or have a legal guardian over the age of 18 to manage the program (for PJIA and SJIA patients under 18 only)
  • Have commercial (private or non-governmental) insurance
  • Do not use a federal or state health insurance program. This includes, but is not limited to, Medicare, Medicaid, Medigap, VA, DoD or TRICARE
  • Do not currently receive help for ACTEMRA from the Genentech Patient Foundation or any independent co-pay assistance foundations
  • Live and are treated in the United States or U.S. Territories
  • Do not live in any state where the program is prohibited by law

Commercial insurance is an insurance plan you get from a private health insurance company. This can be insurance from your job, from a plan you bought yourself or from a Health Insurance Marketplace (for example, from HealthCare.gov). Medicare and Medicaid are not considered commercial insurance.

If you are not eligible for the ACTEMRA Co-pay Program, other options may be available to help you with the out-of-pocket drug costs of ACTEMRA. Visit Genentech-Access.com/ACTEMRA or call (866) 681-3261 for more information.

Indication and Important Safety Information

ACTEMRA is a prescription medicine used:

  • To treat adults with moderately to severely active rheumatoid arthritis (RA) after at least one other medicine called a disease modifying antirheumatic drug (DMARD) has been used and did not work well
  • To treat adults with giant cell arteritis (GCA)
  • To treat people with active polyarticular juvenile idiopathic arthritis (PJIA) 2 years of age and older
  • To treat people with active systemic juvenile idiopathic arthritis (SJIA) 2 years of age and older
  • For slowing the rate of decline in lung function in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD) (also known as scleroderma-associated ILD)

It is not known if ACTEMRA is safe and effective in children with PJIA or SJIA under 2 years of age or in children with conditions other than PJIA or SJIA.

ACTEMRA can cause serious side effects

Serious Infections

ACTEMRA changes the way your immune system works. This can make you more likely to get infections or make any current infection worse. Some people have died from these infections. Your healthcare provider should test you for TB before starting and during treatment with ACTEMRA.

Do not take ACTEMRA if you are allergic to tocilizumab, or any of the ingredients in ACTEMRA.

ACTEMRA can cause other serious side effects. These include:

Tears (perforation) of the Stomach or Intestines
If you have diverticulitis (inflammation in parts of the large intestine), talk to your healthcare provider before taking ACTEMRA. Some people taking ACTEMRA may develop a hole in the wall of their stomach or intestines (also known as a perforation).

Liver problems (Hepatotoxicity)
Some people have experienced serious life-threatening liver problems, which required a liver transplant or led to death. Your healthcare provider may tell you to stop taking ACTEMRA if you develop new or worsening liver problems during treatment with ACTEMRA.

Changes in Blood Test Results
Your healthcare provider should do blood tests before and after you start receiving ACTEMRA. You should not receive ACTEMRA if your neutrophil and platelet counts are too low or your liver function test levels are too high. These may cause your healthcare provider to stop your ACTEMRA treatment for a time or change your dose.

Cancer
ACTEMRA may increase your risk of certain cancers by changing the way your immune system works.

Hepatitis B Infection
If you have or are a carrier of the hepatitis B virus (a virus that affects the liver), the virus may become active while you use ACTEMRA. Your healthcare provider may do blood tests before you start treatment with ACTEMRA and while you are using ACTEMRA.

Serious Allergic Reactions
Serious allergic reactions, including death, can happen with ACTEMRA. These reactions can happen with any infusion or injection of ACTEMRA, even if they did not occur with an earlier infusion or injection.

Nervous System Problems
While rare, Multiple Sclerosis has been diagnosed in people who take ACTEMRA.

The most common side effects of ACTEMRA include:

  • upper respiratory tract infections (common cold, sinus infections)
  • headache
  • increased blood pressure (hypertension)
  • injection site reactions

ACTEMRA & Pregnancy

Tell your healthcare provider if you are planning to become pregnant, are pregnant, plan to breast-feed, or are breast-feeding. If you are pregnant and taking ACTEMRA, join the pregnancy registry. To learn more, call 1-877-311-8972 or talk to your healthcare provider to register.

Tell your healthcare provider if you have any side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Genentech at 1-888-835-2555.

Please see full Prescribing Information and the Medication Guide, including Serious Side Effects, for more Important Safety Information.